نتایج جستجو برای: non alcoholic steatohepatitis

تعداد نتایج: 1341204  

Journal: :International journal of health sciences 2009
Ibrahim M Charanjit Singh M Ashraf Ganie K Alsayari

Non alcoholic fatty liver disease occurs in those who don't consume alcohol in amounts considered harmful to the liver. It represents a spectrum of conditions characterized histologically by mainly macrovesicular hepatic steatosis. There are two histological patterns of NAFLD: fatty liver alone and steatohepatitis. In this brief review, clinical and histologic spectrum, natural history, diagnos...

2017
Mohamed M. Amin Rania F. Ahmed Dalia O. Saleh

Article history: Received on: 02/06/2017 Accepted on: 15/07/2017 Available online: 30/09/2017 Objective: The present study aimed to evaluate the neuro-protective and hepato-protective activity of melatonin (MLN) on non-alcoholic steatohepatitis (NASH) in albino rats induced by methionine and choline deficient (MCD) diet. Material and Methods: To achieve this aim, rats were fed MCD diet for 8 we...

Journal: :Clinical science 2004
Isabelle A Leclercq

This comment discusses the study by Videla and colleagues in this issue of Clinical Science in which they have analysed surgical liver biopsies from obese patients with non-alcoholic fatty liver disease and demonstrate that fatty liver is associated with a state of oxidative stress and a decreased antioxidant activity. As the disease progresses to steatohepatitis, the defect in antioxidant syst...

Journal: :Ibn Al-Haitham Journal For Pure And Applied Science 2023

Non-alcoholic fatty liver disease (NAFLD) is one of chronic and defines by fat accumulation ≥5% in which can progresses to non-alcoholic steatohepatitis (NASH). NAFLD related obesity as well non obese individuals. Adiponectin a cytokine secreted from adipose tissue involved pathogenesis liked with obesity. Irisin myokine, has convenient effect against metabolic diseases such obesity, disylipemi...

2016
Amon Asgharpour Sophie C. Cazanave Tommy Pacana Mulugeta Seneshaw Robert Vincent Bubu A. Banini Divya Prasanna Kumar Kalyani Daita Hae-Ki Min Faridoddin Mirshahi Pierre Bedossa Xiaochen Sun Yujin Hoshida Srinivas V. Koduru Daniel Contaifer Urszula Osinska Warncke Dayanjan S. Wijesinghe Arun J. Sanyal

BACKGROUND & AIMS The lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH) that recapitulates human disease is a barrier to therapeutic development. METHODS A stable isogenic cross between C57BL/6J (B6) and 129S1/SvImJ (S129) mice were fed a high fat diet with ad libitum consumption of glucose and fructose in physiologically relevant concentrations and compared to m...

2011
Mile Janevski Kiriakos N Antonas Melanie J Sullivan-Gunn Maree A McGlynn Paul A Lewandowski

BACKGROUND Non alcoholic steatohepatitis is hypothesised to develop via a mechanism involving fat accumulation and oxidative stress. The current study aimed to investigate if an increase in oxidative stress was associated with changes in the expression of liver fatty acid binding protein in a rat model of non alcoholic steatohepatitis and whether cocoa supplementation attenuated those changes. ...

Journal: :African journal of traditional, complementary, and alternative medicines : AJTCAM 2014
Zheng Yao Xiao-Chen Liu Ying-Er Gu

BACKGROUND he present study aims to explore whether Schisandra chinensis Baill, a Chinese, medicinal herb can alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats. MATERIALS AND METHODS In the study, 24, male Wister rats with body weight between 180-220g, were included. The rats were randomly divided into four groups: model group, normal control group, rosiglitazone group, ...

2011
J K Dowman J W Tomlinson P N Newsome

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent cause of liver disease in Western countries. The development of non-alcoholic steatohepatitis (NASH) and fibrosis identifies an at-risk group with increased risk of cardiovascular and liver-related deaths. The identification and management of this at-risk group remains a clinical challenge. AIM To perform a sys...

2016
Veronica Marin Natalia Rosso Matteo Dal Ben Alan Raseni Manuela Boschelle Cristina Degrassi Ivana Nemeckova Petr Nachtigal Claudio Avellini Claudio Tiribelli Silvia Gazzin

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately...

Journal: :The Israel Medical Association journal : IMAJ 2015
Asnat Raziel Nasser Sakran Amir Szold David Goitein

o besity is a worldwide epidemic with more than 1 billion overweight adults and at least 300 million obese patients [1]. According to recent statistics from the United States, 16.9% of children and adolescents aged 2–19 years were obese in 2009–2010 and 31.8% were either overweight or obese [2]. The rise in childhood obesity has been accompanied by an increase in pediatric liver diseases: 70%–8...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید